From discovery to development

An innovative portfolio for drug development

NGS for Drug Development

Illumina provides an innovative portfolio of genomic sequencing systems, products, and services for the drug development pipeline. With solutions to inform the drug development process, you can confidently choose us as a partner from discovery through companion diagnostics development.

We are uniquely positioned to deliver products and services to support pharmaceutical development with the largest install base of next-generation sequencing (NGS) instrumentation.

Approximately 90 percent of all sequencing data produced today has been generated using Illumina technologies*. Reference and service labs are installing our instruments in increasing numbers to perform a wide variety of applications.

* Data calculations on file. Illumina, Inc. 2015

The Illumina portfolio of solutions informs various stages of the drug development process.

Click on the below to view methods and products supporting drug development.

Whole Genome Sequencing

Take a comprehensive view of the genomic variation linked to a pathway.

Whole Exome Sequencing

Explore genomic variation in a more cost-effective way.

Targeted Cancer Sequencing

Take a deeper view to confirm genomic variation of interest with custom or fixed panels. Detect single-nucleotide variants (SNVs), amplifications, and fusions that contribute to solid tumor progression with TruSight Tumor 170.

Cancer RNA Sequencing

Characterize expression by sequencing individual targets to the entire transcriptome.

Immunotherapy Research

NGS methods enable efficient, broad, and deep assessment of tumors and their microenvironment.

Sequencing Systems

Find the sequencer that best fits your scale of study.

Microarray Solutions

A complete range of tools and services for every need.

Informatics

Bioinformatics tools guide you from experimental design to data interpretation and reporting.

Services

Find a service provider through our Propel program to support your genomics needs.

Targeted Cancer Sequencing

Take a deeper view to confirm genomic variation of interest with custom or fixed panels. Detect single-nucleotide variants (SNVs), amplifications, and fusions that contribute to solid tumor progression with TruSight Tumor 170.

Cancer RNA Sequencing

Confirm expression in transcripts of interest with targeted panels and access hard to analyze FFPE samples.

Immunotherapy Research

NGS methods enable efficient, broad, and deep assessment of tumors and their microenvironment

Sequencing Systems

Find the sequencer that best fits your scale of study.

Informatics

Bioinformatics tools guide you from experimental design to data interpretation and reporting.

Services

Find a service provider through our Propel program to support your genomics needs.

Targeted Cancer Sequencing

Take a deeper view to confirm genomic variation of interest with custom or fixed panels. Detect single-nucleotide variants (SNVs), amplifications, and fusions that contribute to solid tumor progression with TruSight Tumor 170.

Cancer RNA Sequencing

Confirm expression in transcripts of interest with targeted panels and access hard to analyze FFPE samples.

Immunotherapy Research

NGS methods enable efficient, broad, and deep assessment of tumors and their microenvironment

Sequencing Systems

Find the sequencer that best fits your scale of study.

Informatics

Bioinformatics tools guide you from experimental design to data interpretation and reporting.

Services

Find a service provider through our Propel program to support your genomics needs.

Explore Illumina’s unique, multi-analyte approach to co-development.

Targeted Cancer Sequencing

Take a deeper view to confirm genomic variation of interest with custom or fixed panels. Detect single-nucleotide variants (SNVs), amplifications, and fusions that contribute to solid tumor progression with TruSight Tumor 170.

Cancer RNA Sequencing

Confirm expression in transcripts of interest with targeted panels and access hard to analyze FFPE samples.

Immunotherapy Research

NGS methods enable efficient, broad, and deep assessment of tumors and their microenvironment.

Sequencing Systems

Find the sequencer that best fits your scale of study.

Companion Diagnostic Development

Explore Illumina’s unique, multi-analyte approach to co-development.

Biobank Tools

Gain meaningful insights from complex populations.

Informatics

Bioinformatics tools guide you from experimental design to data interpretation and reporting.

Services

Find a service provider through our Propel program to support your genomics needs.

Companion Diagnostic Development

Explore Illumina’s unique, multi-analyte approach to co-development.

MiSeqDx

Discover the first FDA-cleared next-generation sequencing system.

Biobank Tools

Gain meaningful insights from complex populations.

Services

Find a service provider through our Propel program to support your genomics needs.

Interested in receiving newsletters, case studies, and information on genomics in drug development? Enter your email address.
Immunotherapy Research and NGS
Immunotherapy Research and NGS

An overview of exciting new fields of immunotherapy research, and how NGS helps to move them forward.

View PDF
How Genomics is Shaping the Future of Oncology
How Genomics is Shaping the Future of Oncology

Read an interview with John Leite, VP of Marketing for Illumina’s Oncology business.

Read Interview
Aiming for a Standard Method in Clinical Research
Aiming for a Standard Method in Clinical Research

Almac Diagnostics is using the TruSight Tumor 170 assay for comprehensive high-quality genomic content in one streamlined workflow.

Read Article
Scaling NGS to Deliver Discoveries
Scaling NGS to Deliver Discoveries

Regeneron discusses their latest work and overall mission to explore new variations in genomes that can help explain disease.

View Video
View Video
NGS Used for Biological QC in BioPharma Production
NGS Used for Biological QC in BioPharma Production

Read how Merck Serono uses NGS for cell line stability testing and biosafety monitoring.

Access PDF
Service Partners and Programs
Service Partners and Programs

The Propel Certification Program is designed to promote high data quality and best practices at fee-for-service labs powered by Illumina.

Learn More
Analysis Tools to Inform Drug Discovery and Development
Analysis Tools to Inform Drug Discovery and Development

Analyze complex genomic data in novel ways across the entire drug discovery and development process.

View Tools